News

Welcoming RISE Cohort 10 for summer institute

Below are introductions to the amazing researchers who make up the final cohort of Research in Implementation Science for Equity (RISE). This program has empowered a host of health advocates and researchers whose lasting contributions are only beginning.

Replay: Best Practices for Research on Racial and Ethnic Inequalities in Cognitive Aging and Dementia

   

Understanding the genesis of cancer is goal of $25 million award

A world-class team of researchers co-led by UC San Francisco’s Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development. Cancer Grand Challenges is a global funding platform, co-founded by Cancer...

New faculty member Jennifer Velloza advocates for mixed methods and implementation science

Jennifer Velloza, PhD, recently joined UCSF as a faculty member at IGHS, the Department of Epidemiology and Biostatistics and its affiliated center, PRISE, to work at the intersection of

Amid global shortage, study shows how to cut contrast dye use 83%

As a worldwide shortage of contrast dye for medical imaging continues, a new UC San Francisco research letter in JAMA quantified strategies medical facilities can employ to safely reduce dye use in computed tomography (CT) by up to 83%.

How much does travel affect global efforts to treat HIV?

Since the onset of the HIV/AIDS epidemic in the early 1980s, health officials and researchers have known that travel would be an important factor: Simply put, travel spreads disease.

Leadership transition in the Department of Epidemiology and Biostatistics

Even beyond hospital walls, COVID-19 hit marginalized communities hardest

The emergence of COVID-19 in the United States in March 2020 affected mortality patterns well beyond the walls of busy intensive care units. Data from the U.S. Department of Transportation showed, for instance, that, although Americans drove less, there were more traffic deaths. A report published...

COVID drug may also ease symptoms of long COVID

An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.

Why doctors are prescribing nature walks

In early April 2022, about two dozen children and their families gathered beneath the redwoods in a regional park near Oakland, Calif. They sat with a physician, Dr. Nooshin Razani, beneath the branches of the ancient giants, breathing the fresh air and discussing the phenomenon of fairy rings—when...